2289 — Charmacy Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- HK$837.00m
- HK$1.16bn
- CNY4.44bn
- 23
- 82
- 37
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.27 | ||
| Price to Tang. Book | 1.46 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.18 | ||
| EV to EBITDA | 8.07 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.96% | ||
| Return on Equity | 8.76% | ||
| Operating Margin | 1.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 3,991.71 | 3,793.62 | 4,175.28 | 4,403.63 | 4,435.46 | n/a | n/a | 4.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +0.88 | -41.01 | +74.42 | +24.15 | +2.49 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Charmacy Pharmaceutical Co Ltd is a China-based company principally engaged in the distribution of pharmaceutical products. The Company mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals, while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products related consulting services. The Company's businesses cover the entire supply chain for pharmaceutical distribution, including procurement, sales, warehousing, transportation and delivery. The Company operates its businesses primarily in the domestic market.
Directors
- Chuanglong Yao CHM (45)
- Zhixiong Lin CFO
- Jianbo Fan CTO (39)
- Yuyan Zheng CMO (40)
- Zhijie Lin OTH (33)
- Weisheng Li NED (52)
- Jian Guan NID (45)
- Chi Wai Wan NID (44)
- Tao Zhou NID (32)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 18th, 1984
- Public Since
- December 14th, 2015
- No. of Employees
- 847
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 108,000,000
- Address
- No. 235, SHANTOU, 515041
- Web
- https://www.chmyy.com/
- Phone
- +86 75488206420
- Auditors
- SHINEWING (HK) CPA LIMITED
Upcoming Events for 2289
Similar to 2289
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Charmacy Pharmaceutical Co share price?
As of Today at 19:52 UTC, shares in Charmacy Pharmaceutical Co are trading at HK$7.75. This share price information is delayed by 15 minutes.
How has the Charmacy Pharmaceutical Co share price performed this year?
Shares in Charmacy Pharmaceutical Co last closed at HK$7.75 and the price had moved by -44.56% over the past 365 days. In terms of relative price strength the Charmacy Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -43.93% over the past year.
What are the analyst and broker recommendations for Charmacy Pharmaceutical Co?
The overall consensus recommendation for Charmacy Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Charmacy Pharmaceutical Co dividend yield?
The Charmacy Pharmaceutical Co dividend yield is 6.18% based on the trailing twelve month period.
Does Charmacy Pharmaceutical Co pay a dividend?
Last year, Charmacy Pharmaceutical Co paid a total dividend of CNY0.45, and it currently has a trailing dividend yield of 6.18%. We do not have any data on when Charmacy Pharmaceutical Co is to next pay dividends.
When does Charmacy Pharmaceutical Co next pay dividends?
We do not have data on when Charmacy Pharmaceutical Co is to next pay dividends. The historic dividend yield on Charmacy Pharmaceutical Co shares is currently 6.18%.
How do I buy Charmacy Pharmaceutical Co shares?
To buy shares in Charmacy Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Charmacy Pharmaceutical Co?
As of the previous close price of HK$7.75, shares in Charmacy Pharmaceutical Co had a market capitalisation of HK$837.00m.
Where are Charmacy Pharmaceutical Co shares listed?
Here are the trading details for Charmacy Pharmaceutical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2289
What kind of share is Charmacy Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Charmacy Pharmaceutical Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Charmacy Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in Charmacy Pharmaceutical Co is HK$9.36. That is 20.74% above the last closing price of HK$7.75.
Analysts covering Charmacy Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Charmacy Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Charmacy Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.75%.
As of the last closing price of HK$7.75, shares in Charmacy Pharmaceutical Co were trading -9.02% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Charmacy Pharmaceutical Co PE Ratio?
The Charmacy Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$7.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Charmacy Pharmaceutical Co?
Charmacy Pharmaceutical Co's management team is headed by:
- Chuanglong Yao - CHM
- Zhixiong Lin - CFO
- Jianbo Fan - CTO
- Yuyan Zheng - CMO
- Zhijie Lin - OTH
- Weisheng Li - NED
- Jian Guan - NID
- Chi Wai Wan - NID
- Tao Zhou - NID